Form 4 for MBIO MUSTANG BIO, INC.
Accepted 2024-06-04 00:00:00 ET · period of report 2022-04-24 · accession 0001104659-24-068409 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-06-04 | 2022-04-24+ | MBIO | Litchman Manuel MD | Pres, CEO, Dir | F - Tax | $7.72 | -2,820 | 81.0K | -3% | -$21.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-24 | F | D | 1,572 | $4.21 | 79,420 | D | — | — | (F3) 1,572 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units. |
| 2 | Common | Common Stock | 2022-04-24 | F | D | 1,248 | $12.15 | 80,992 | D | — | — | (F1) 1,248 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units. (F4) Includes 3,975 shares of common stock acquired under the Mustang Bio, Inc. Employee Stock Purchase Plan on March 1, 2023 and September 1, 2023. (F2) The amount of common stock reflected on this Form 4 has been adjusted to reflect a 1-for-15 reverse stock split that occurred subsequent to this transaction. |